NeOnc signs definitive agreement for $50M strategic partnership with Quazar

NeOnc Technologies (NTHI) announced it has it has signed a definitive agreement for a $50M strategic partnership with Quazar Investment. The definitive agreement follows NeOnc’s Board unanimously approving the company’s participation in the contemplated $50 million equity investment and MENA region expansion, reflecting continued momentum. Under definitive agreement, Quazar intends to lead a capital formation round of up to $50 million, priced at $25 per share. The proposed structure allocates 70% of proceeds to the acquisition of NeOnc common stock, with 30% earmarked for launching clinical trials and building infrastructure across the UAE and broader MENA region.